Exploring the regenerative capacity of the spleen following irradiation

IntroductionHaematopoietic stem cell transplantation (HSCT) is commonly used to treat patients with haematological disorders. Myeloablative conditioning is an important preparation for patients receiving haematopoietic stem cells (HSC) or haematopoietic stem and progenitor cells (HSPC). While widely...

Full description

Saved in:
Bibliographic Details
Main Authors: Christie T. M. Short, Helen C. O’Neill, Jonathan K. H. Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Hematology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frhem.2024.1396672/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846156414271094784
author Christie T. M. Short
Helen C. O’Neill
Jonathan K. H. Tan
author_facet Christie T. M. Short
Helen C. O’Neill
Jonathan K. H. Tan
author_sort Christie T. M. Short
collection DOAJ
description IntroductionHaematopoietic stem cell transplantation (HSCT) is commonly used to treat patients with haematological disorders. Myeloablative conditioning is an important preparation for patients receiving haematopoietic stem cells (HSC) or haematopoietic stem and progenitor cells (HSPC). While widely successful, HSCT is still associated with high rates of mortality. The recovery time between complete myeloablation and haematopoietic recovery is a large factor in the recovery rate. Successful engraftment of HSC is also directly correlated with the number of HSC niches available. This highlights the importance of the haematopoietic niche and its recovery from myeloablation as an important therapeutic target.MethodsThis murine model study specifically considers changes in spleen tissue architecture and cellular composition involving stromal and vascular cells that occur following lethal irradiation.ResultsSpleen recovered fully between 4- and 8-weeks after irradiation due to reconstitution by HSPC from bone marrow. Specific temporal changes in spleen architecture were identified, and these were linked to the cell types that constitute the white pulp, red pulp and marginal zones. Mesenchymal stromal cells returned before endothelial cells, and reticular cell types recovered more quickly in spleen following irradiation. Losses in gp38+ fibroblastic reticular cells and MAdCAM-1+ marginal reticular cells were associated with loss of the white pulp in the first 4 weeks following irradiation. White pulp was restored following recovery of supporting reticular cells.DiscussionThis study tests how spleen regeneration following a lethal dose of irradiation can be influenced by co-infusion of bone marrow HSPC together with either neonatal spleen stromal cells, or cells of the stromal STX3 line. Both the infusion of neonatal spleen stromal cells and STX3 stromal cells hastened recovery of both mesenchymal and vascular compartments. Following neonatal spleen stromal cell infusion, endothelial cells increased early, but a delay in structural reformation of distinct red and white pulp areas was found. Results from this study show that spleen regeneration can be influenced and even hastened through cellular therapy. Neonatal spleen stromal cells, co-infused together with HSPC following irradiation conditioning, represent a potential therapeutic opportunity for hastening spleen regeneration.
format Article
id doaj-art-ca29f624d8154715ae48017ca32e46f0
institution Kabale University
issn 2813-3935
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Hematology
spelling doaj-art-ca29f624d8154715ae48017ca32e46f02024-11-26T06:26:30ZengFrontiers Media S.A.Frontiers in Hematology2813-39352024-11-01310.3389/frhem.2024.13966721396672Exploring the regenerative capacity of the spleen following irradiationChristie T. M. ShortHelen C. O’NeillJonathan K. H. TanIntroductionHaematopoietic stem cell transplantation (HSCT) is commonly used to treat patients with haematological disorders. Myeloablative conditioning is an important preparation for patients receiving haematopoietic stem cells (HSC) or haematopoietic stem and progenitor cells (HSPC). While widely successful, HSCT is still associated with high rates of mortality. The recovery time between complete myeloablation and haematopoietic recovery is a large factor in the recovery rate. Successful engraftment of HSC is also directly correlated with the number of HSC niches available. This highlights the importance of the haematopoietic niche and its recovery from myeloablation as an important therapeutic target.MethodsThis murine model study specifically considers changes in spleen tissue architecture and cellular composition involving stromal and vascular cells that occur following lethal irradiation.ResultsSpleen recovered fully between 4- and 8-weeks after irradiation due to reconstitution by HSPC from bone marrow. Specific temporal changes in spleen architecture were identified, and these were linked to the cell types that constitute the white pulp, red pulp and marginal zones. Mesenchymal stromal cells returned before endothelial cells, and reticular cell types recovered more quickly in spleen following irradiation. Losses in gp38+ fibroblastic reticular cells and MAdCAM-1+ marginal reticular cells were associated with loss of the white pulp in the first 4 weeks following irradiation. White pulp was restored following recovery of supporting reticular cells.DiscussionThis study tests how spleen regeneration following a lethal dose of irradiation can be influenced by co-infusion of bone marrow HSPC together with either neonatal spleen stromal cells, or cells of the stromal STX3 line. Both the infusion of neonatal spleen stromal cells and STX3 stromal cells hastened recovery of both mesenchymal and vascular compartments. Following neonatal spleen stromal cell infusion, endothelial cells increased early, but a delay in structural reformation of distinct red and white pulp areas was found. Results from this study show that spleen regeneration can be influenced and even hastened through cellular therapy. Neonatal spleen stromal cells, co-infused together with HSPC following irradiation conditioning, represent a potential therapeutic opportunity for hastening spleen regeneration.https://www.frontiersin.org/articles/10.3389/frhem.2024.1396672/fullhaematopoiesishaematopoietic stem cell nichespleenbone marrowirradiationregeneration
spellingShingle Christie T. M. Short
Helen C. O’Neill
Jonathan K. H. Tan
Exploring the regenerative capacity of the spleen following irradiation
Frontiers in Hematology
haematopoiesis
haematopoietic stem cell niche
spleen
bone marrow
irradiation
regeneration
title Exploring the regenerative capacity of the spleen following irradiation
title_full Exploring the regenerative capacity of the spleen following irradiation
title_fullStr Exploring the regenerative capacity of the spleen following irradiation
title_full_unstemmed Exploring the regenerative capacity of the spleen following irradiation
title_short Exploring the regenerative capacity of the spleen following irradiation
title_sort exploring the regenerative capacity of the spleen following irradiation
topic haematopoiesis
haematopoietic stem cell niche
spleen
bone marrow
irradiation
regeneration
url https://www.frontiersin.org/articles/10.3389/frhem.2024.1396672/full
work_keys_str_mv AT christietmshort exploringtheregenerativecapacityofthespleenfollowingirradiation
AT helenconeill exploringtheregenerativecapacityofthespleenfollowingirradiation
AT jonathankhtan exploringtheregenerativecapacityofthespleenfollowingirradiation